The marijuana stock market has shifted very rapidly over the course of the past few years. With so many pot stocks to watch and pot stocks to choose from, it seems as though the choice can be quite difficult. This choice, however, is just the reason you’re here. One of the key things to note about pot stocks is that they come from all around the industry. Companies in the cannabis stock market can be ancillary businesses such as marketing and packaging companies. Additionally, they can also be the raw growers of the substance itself.

All of these varying businesses have different reasons that make them pot stocks to watch. One of the key things to note is that these companies do usually come with a higher level of volatility than most. This is simply due to the fact that the pot stock market is still very much one of infancy. Volatility, however, can be positive for some investors as it allows for larger gains. One should keep in mind that it also can account for larger losses. All in all, these marijuana stocks to watch are working to shift the future of the industry for the better.

A Scientific Approach to Cannabis

Stilcanna Inc. (STIL Stock Report) (SCNNF Stock Report) is one of the leading CBD based businesses currently working out of the European extraction market. The company has stated that its proprietary technology allows them to have a larger scale CBD operation at a lower cost than most other competitors in the pot stock market. Within Europe, they have already signed into an exclusive contract for Dragonfly Biosciences LLC, a UK based CBD supplier. The company has stated that they also are working on the acquisition of other businesses in the pot stock market. With this, they should be able to grow their influence within the marijuana stock market overall and more specifically in Europe.

marijuana stocks to watch StillCanna logo

The company recently put out an operational update regarding their extraction facility based in Romania. With this new venture, they should be able to double the capacity of their current extraction equipment, where they then can fine-tune it to be fully up for industrial-scale production. When the machines are up and running, they will hopefully be able to produce any mixture of CBD-related compounds that a customer could order. For this reason among others, they remain a key pot stock to watch moving forward.

An Ancillary Pot Stock to Consider

KushCo Holdings (KSHB Stock Report) is one of the leading ancillary pot stocks in the market. The company has gone from a packaging solutions business to one with many facets spanning the whole pot stock market. The company currently operates in several different aspects of the cannabis stock market.

This includes extraction technology, infused edibles, packaging and branding solutions and more. Because they have such a broad scope, it seems as though they remain an interesting pot stock to watch. The company has made sure that they are working toward shifting the future of the pot stock market overall as it inevitably continues to change.


Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of, Midam Ventures LLC and Stillcanna (STIL) (SCNNF) (formerly known as EVI Global Group Developments Corp), Midam is being paid $150,000 for coverage on Stillcanna (STIL) (SCNNF), for a period from September 9, 2019 to December 25, 2019. We may buy or sell additional shares of Stillcanna (STIL) (SCNNF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Stillcanna (STIL) (SCNNF). For Full Disclaimer Click Here 

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Marijuana Stocks Top Trending Articles On Black Friday – 11/24/2017

Today’s Black Friday But All We See Is GREEN! Here’s What’s Trending…

Why Is Big Pharma Making Road Blocks Towards Legalizing Marijuana

A heavy cash donation from a prescription drug company to battle against…